Speaker: Nader Fotouhi, Chief Scientific Officer, TB Alliance (US)
Moderator: Lydia Nakiyingi, infectious diseases physician, research scientist and senior lecturer, Makerere University College of Health Sciences (Uganda)
Nader’s presentation discussed:
- 20 Years of Impact: Introduction to TB Alliance and an overview of TB drug development in the 21st century
- The TB drug discovery and development landscape today: state of the global pipeline and survey of TB Alliance’s programs
- Case study: a new therapy for highly drug-resistant forms of TB
- Where do we go from here? New partnerships and new treatment paradigms to reimagine TB treatment
This live webinar including interactive Q&A session was broadcast on 24 March 2021.
If you have questions or comments, please let us know: email@example.com.